ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Lithium

Also written as “lithium” and “lithium (mood stabilizer)”.

Its studies are mostly in Bipolar Disorder · Mania · Alcoholism, led by 3 companies.

Drug pageLithium: every studyAll 70 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Jun 29, 200910 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AstraZenecaits history only50 open or runningphase 4since Jun 29, 2009Apr 9, 2004none ahead
Hikma Pharmaceuticalsits history only40 open or runningno phasesince Sep 19, 2007Sep 19, 2007none ahead
Bristol-Myers Squibb10 open or runningphase 1since Dec 9, 2024Dec 9, 2024none ahead

Also a collaborator on its studies: Quintiles.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Bristol-Myers Squibb only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 9, 2024First study: phase 1 study in Healthy VolunteersFirst studyNCT06729970 · 133 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Bristol-Myers Squibb leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06729970Healthy Volunteers · United States1CompletedJan 23, 2026133

How it is read

Names in the registry

  • “Lithium”, 7 entries
  • “lithium”, 2 entries
  • “lithium (mood stabilizer)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.